MedPath

A Study of transplantation of autologous induced pluripotent stem cell (iPSC) derived retinal pigment epithelium (RPE) cell sheet in subjects with exudative age related macular degeneratio

Not Applicable
Conditions
Exudative age related macular degeneration
Registration Number
JPRN-UMIN000011929
Lead Sponsor
RIKE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
1
Inclusion Criteria

Not provided

Exclusion Criteria

1) Presence of ocular infection 2) Presence of other retinal diseases such as diabetic retinopathy, hypertensive retinopathy, retinal vessel occlusions. 3) Presence of optic nerve atrophy 4) Presence of glaucoma of uncontrolled ocular pressure 5) Presence of significant hepatic failure (with either AST or ALT higher than 100 IU/L) 6) Presence of renal failure 7) Negative serum tests for human immunodeficiency virus (HIV), hepatitis B (HBV), hepatitis C (HCV) or syphilis. 8)No history of allergic reaction to antibiotics or bovine serum 9) No medical requirements for a continuous treatment of anti-coagulants or anti-platelets 10) Medically suitable for general anesthesia 11) No presence of or history of malignancy in past 5 years 12) No history of allergic reaction to ICG or Fluorescein 13) Pregnant females; breastfeeding females; and females of childbearing potential. 14) No participation in other clinical trials that involve the last one month before informed consent is obtained 15) Medically judged inadequate by the docters responsible for this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Safety of the proposed treatment protocol: incidence and severity of adverse events related to the use of autologous iPSC derived RPE sheet. <Adverse events related to iPSC derived RPE sheet> 1 Poor survival of the graft, immune rejection 2 Tumor formation <Adverse events related to surgical procedure> 1. Retinal detachment, choroidal hemorrhage, vitreous hemorrhage 2 Retinal tear and retinal detachment
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath